2型糖尿病患者的EAT-Lancet饮食坚持:一个跨部分研究
Meltem Karabicak1, Aysun Yuksel2
1Sisli Hamidiye Etfal Training and Research Hospital Istanbul Türkiye.
Food science & nutrition
|July 21, 2025
概括
在2型糖尿病患者中遵守EAT-Lancet饮食与更好的血糖控制和改善健康有关. 促进这种可持续的饮食模式可以提高公共卫生和环境可持续性.
科学领域:
- 营养科学 营养科学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 2型糖尿病的管理通常涉及饮食干预.
- EAT-Lancet饮食为健康和可持续的饮食提供了一个框架.
- 评估糖尿病患者群体对这种饮食的坚持至关重要.
研究的目的:
- 评估2型糖尿病患者遵守EAT-Lancet饮食的情况.
- 调查EAT-Lancet饮食坚持和健康参数之间的关联.
- 探索社会人口统计学因素对饮食坚持的影响.
主要方法:
- 这是一项涉及385名2型糖尿病患者的横截面研究.
- 数据收集包括一般信息,生化和人体测量测量,24小时饮食回忆和食物频率问卷.
- 使用EAT-Lancet饮食指数评估饮食坚持.
主要成果:
- 较高的EAT-Lancet饮食坚持与增加的纤维摄入量和减少的能量,蛋白质和脂肪消耗相关.
- 在EAT-Lancet饮食指数和糖尿病持续时间之间发现了正相关性 (p=0.03).
- 在EAT-Lancet饮食指数和禁食血糖之间观察到负相关性 (p=0.02),表明更好的血糖控制和更低的HbA1c水平与更高的坚持. 年龄较大的个体表现出更强的坚持.
结论:
- 坚持EAT-Lancet饮食与改善血糖控制和2型糖尿病的健康结果显著相关.
- 促进可持续饮食的政策干预和教育计划可以有利于公众健康和环境可持续性.
- 将可持续营养融入饮食指南中可能会改善糖尿病患者的坚持.
更多相关视频
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
1.2K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
379
相关概念视频
Carbohydrate Metabolism
11.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.8K
Diabetes: Management and Pharmacotherapy
399
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
399
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Insulin: Dosing Regimen and Adverse Effects
262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262
Diabetes: Symptoms, Diagnosis, and Complications
697
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
697
